CHEMRES | Linksium
Back to portfolio

CHEMRES

Maturation

Make anticancer drugs active again

profilePhoto   Valentine Panel
Linksium Contact Valentine Panel +33 (0)6 35 81 73 67 valentine.panel@linksium.fr
190012 CHEMRES

Benefits

  • Time extension of anticancer drug using
  • Efflux inhibition of anticancer agents
  • Improvement of the efficiency and comfort of the chemotherapy

Key words

  • Cancer
  • Chemotherapy
  • Multidrug resistance
  • Protein
  • Inhibitor

Intellectual Property

  • 1 patent

Partnerships & Rewards

  • Région Auvergne-Rhône-Alpes
  • i-PhD winner - 2021

Laboratory

  • DPM

Institution

  • UGA

Linksium Continuum

  • Maturation

Context

Cancer is a major health issue with growing economic impact, supported by our society. These are two reasons why the research for long-term and effective new treatments is constantly evolving and funded by numerous sources of funding.

Technology

The CHEMRES project aims to develop an active, selective, and non-toxic inhibitor of a protein involved in multidrug resistance to chemotherapy. Its therapeutic potential should be reached when used in combination with an anticancer drug.

Advantages

Multidrug resistance is one of the main causes of chemotherapy failure. Restoring tumour cells sensitivity to treatment would make chemotherapy more effective while reducing the number of side and/or adverse effects as well as the cost and duration of treatment.

State of progress

Preliminary in vitro studies have allowed us to identify a series of molecules of therapeutic interest. Their synthesis was scaled-up for a production of several grams in order to start the steps of formulation and biological evaluation in vivo.

Applications

We are considering a therapeutic protocol which would be to use a combination of our inhibitor and an anticancer drug in order to allow the latter to overcome the acquired resistance and thus fully restore its effectiveness. In addition, our molecules being selective, they could serve as a diagnostic tool.

In the magazine

Nora Dempsey and deeptech innovations

1, 2 and 3 startups for Nora Dempsey, National Medal of Innovation 2021

Nora Dempsey is one of the four winners of National Medal for Innovation 2021 awarded by CNRS. Nora Dempsey, born in Ireland, has gained an international recognition for her research in Grenoble on...

Read the article
Dd amiral 2018 Frenchweb

Amiral Technologies, la startup IA grenobloise spécialisée dans les solutions de maintenance prédictive, intègre Station F

An ambitious promise: to invent a zero-defect and zero-downtime future for industry. Amiral Technologies, a startup co-founded and boosted by Linksium, based on the technological prowess of the Gre...

Read the article